Your email has been successfully added to our mailing list.

×
0.000382189948404281 -0.00191094974202181 -0.0185362124976114 -0.0177718326008026 -0.0196827823428244 -0.0191094974202178 -0.0120389833747373 -0.0129944582457481
Stock impact report

Moderna submits IND application for Phase 2 COVID-19 study [Seeking Alpha]

Moderna, Inc. (MRNA) 
Last moderna, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: marinabio.com/investor-relations
Company Research Source: Seeking Alpha
Moderna (NASDAQ:MRNAThe company has received initial feedback from the FDA on the design of the planned Phase 2 trial, which is seen beginning this quarter. The study will evaluate the safety, reactogenicity and immunogenicity of two vaccinations of mRNA-1273 given 28 days apart.Source:Press ReleaseShares are little-changed in after hours action. They weredown 4.85% Show less Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MRNA alerts
Opt-in for
MRNA alerts

from News Quantified
Opt-in for
MRNA alerts

from News Quantified